ilShinbiobase Co. Ltd (068330) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.006x

Based on the latest financial reports, ilShinbiobase Co. Ltd (068330) has a cash flow conversion efficiency ratio of 0.006x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩426.36 Million ≈ $288.94K USD) by net assets (₩67.09 Billion ≈ $45.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 068330 market cap for the company's overall valuation and market capitalisation.

ilShinbiobase Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how ilShinbiobase Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ilShinbiobase Co. Ltd stock price for real-time trading data and today's change.

ilShinbiobase Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ilShinbiobase Co. Ltd ranked by their cash flow conversion efficiency. Review ilShinbiobase Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Texxon Holding Ltd. NASDAQ:NPT	N/A
RMG Acquisition Corp. III NASDAQ:RMGCF	0.034x
Mishorim Real Estate Investments TA:MSHR	0.005x
5TH PLANET GAMES DK -50 F:2HG1	-0.027x
Jade Marvel Group Bhd KLSE:7043	0.010x
Daechang Steel Co Ltd KQ:140520	-0.048x
Pritika Auto Industries Limited NSE:PRITIKAUTO	0.142x
MINDMAZE THERAPEUTICS HOLDING SA SW:MMTX	N/A

Annual Cash Flow Conversion Efficiency for ilShinbiobase Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of ilShinbiobase Co. Ltd from 2014 to 2025. Also see 068330 current and non-current assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩64.80 Billion ≈ $43.91 Million	₩5.27 Billion ≈ $3.57 Million	0.081x	+19.22%
2024-12-31	₩60.45 Billion ≈ $40.97 Million	₩4.12 Billion ≈ $2.79 Million	0.068x	-34.34%
2023-12-31	₩57.06 Billion ≈ $38.67 Million	₩5.92 Billion ≈ $4.01 Million	0.104x	+111.12%
2022-12-31	₩53.82 Billion ≈ $36.47 Million	₩2.65 Billion ≈ $1.79 Million	0.049x	-63.21%
2021-12-31	₩50.47 Billion ≈ $34.20 Million	₩6.74 Billion ≈ $4.57 Million	0.134x	+31.71%
2020-12-31	₩44.38 Billion ≈ $30.08 Million	₩4.50 Billion ≈ $3.05 Million	0.101x	-26.55%
2019-12-31	₩40.16 Billion ≈ $27.22 Million	₩5.55 Billion ≈ $3.76 Million	0.138x	+1.17%
2018-12-31	₩35.72 Billion ≈ $24.20 Million	₩4.88 Billion ≈ $3.31 Million	0.137x	+127.43%
2017-12-31	₩35.22 Billion ≈ $23.87 Million	₩2.11 Billion ≈ $1.43 Million	0.060x	-34.18%
2016-12-31	₩32.98 Billion ≈ $22.35 Million	₩3.01 Billion ≈ $2.04 Million	0.091x	+719.39%
2015-12-31	₩24.27 Billion ≈ $16.45 Million	₩270.22 Million ≈ $183.12K	0.011x	-91.87%
2014-12-31	₩24.30 Billion ≈ $16.47 Million	₩3.33 Billion ≈ $2.25 Million	0.137x	--

About ilShinbiobase Co. Ltd

KQ:068330 Korea

Market Cap

$28.60 Million

₩42.20 Billion KRW

Market Cap Rank

#24001 Global

#1687 in Korea

Share Price

₩1012.00

Change (1 day)

-0.88%

52-Week Range

₩863.00 - ₩1127.00

All Time High

₩1127.00